Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXYTAHANE: Oxygen Therapy for Attacks in Alternating Hemiplegia of Childhood
NCT06248645Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2024
- Primary completion
- Mar 2026
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of oxygen in alternating hemiplegia of childhood (AHC), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2024; status: completed.
02
Drugs
oxygen
03
Conditions
alternating hemiplegia of childhood (AHC)
Beyond the preview
Go deeper on NCT06248645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06248645.